Skip to content

Acupressure and premenstrual syndrome (PMS)

Effect of acupressure on quality of life in girls with PMS

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016060828038N2
Enrollment
90
Registered
2016-06-14
Start date
2015-03-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premenstrual syndome. Premenstrual tension syndrome

Interventions

Intervention 1: First intervention: Acupressure done in the third hepatic point that located at dorsal surface of the foot between the first and second toes at the point of bones junction. Interventio
First intervention: Acupressure done in the third hepatic point that located at dorsal surface of the foot between the first and second toes at the point of bones junction.
Second intervention: Acupressure done in the large intestine point that located at the dorsal surface of the hand between thumb and index finger approximately at the middle of the second metacarpus bo
Third intervention: Acupressure done in the placebo point that located at dorsal surface of the foot between the third and the forth toes which is not in the line of meridian.

Sponsors

Vice chancellor of research of Hormozgan University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age of 18-45; passing at least two hours after the last meal; having moderate to severe PMS according to the score of premenstrual symptoms screening tool Exclusion criteria: Infectious or skin diseases; acute rheumatoid arthritis; lesion or dermatitis at the site of applying pressure; visual or auditory impairment; avoid taking analgesics for three hours before starting the intervention; severe psychological tension during the last six months (loss of relatives, surgery, etc); heart disease, renal disorder, diabetes, asthma, hypothyroidism or hyperthyroidism, respiratory disorder; genital disease; interval between menstruation lower than 21 or upper than 35 days; PMS in all menstrual cycle

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
PMS severity. Timepoint: Start of mensuration in two cycles. Method of measurement: Premenstrual symptoms screening tool.

Secondary

MeasureTime frame
Quality of life. Timepoint: Start of menstruation in two cycles. Method of measurement: SF-12 quality of life questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Bazarganipour

Hormozgan University of Medical Sciences

bazarganipour@hums.ac.ir; f.bazarganipour@gmail.com+98 76 3333 7192

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026